Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family. 

Biotechnology

Education

Pyramid Biosciences

Pyramid Biosciences' headquarters in Waltham, MA, United States

Jeffrey Wasserman

Biren Amin

Nushmia Khokhar

Keith Brosie

Deb Chapman

Moses Chao

Vlad Coric

John Childs

Timothy Cloughsey

Daniel Cahill

John Sampson

Larry Feinberg

David Reardon

Lori Kunkel

Michael Lim

Dave Solit

Katherine Warren

Dana Farber

Manmeet Ahluwalia

George Demetri

Aleksander Rabodzey

The Scientific Team at Pyramid Biosciences conducts cutting-edge research to identify and develop new therapeutic compounds targeting tropomyosin receptor kinase (TRK) family-related disorders. This team of twelve Scientific Advisors collaborates to advance scientific understanding and innovation in TRK-targeted treatments.

Scientific Team

The Leadership Team at Pyramid Biosciences is responsible for guiding the company's strategic direction, ensuring compliance with legal and regulatory standards, and overseeing the financial health of the organization. Comprising the Chief Legal Officer, Chief Financial & Strategy Officer, and Chief Medical Officer, this team collaborates to drive innovation in targeted therapeutics and align the company's objectives with its mission to address disorders governed by the TRK family.

Leadership Team

Pyramid Biosciences

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Pyramid Biosciences

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies